Detailed Mechanism Funding and Narrative

Years of mechanism: 2019 2020

Details for Mechanism ID: 109135
Country/Region: South Sudan
Year: 2019
Main Partner: U.S. Centers for Disease Control and Prevention
Main Partner Program: NA
Organizational Type: Own Agency
Funding Agency: HHS/CDC
Total Funding: $639,913 Additional Pipeline Funding: $1,260,087

Mechanism Allocation by Budget Code for Selected Year
Laboratory Infrastructure (HLAB) $54,952
Biomedical Prevention: Blood Safety (HMBL) $9,158
Treatment: ARV Drugs (HTXD) $29,918
Treatment: Adult Treatment (HTXS) $238,146
Testing: HIV Testing and Counseling (HVCT) $18,317
Management and Operations (HVMS) $167,308
Strategic Information (HVSI) $64,111
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $9,158
Health Systems Strengthening (OHSS) $18,317
Treatment: Pediatric Treatment (PDTX) $24,423
Care: TB/HIV (HVTB) $6,105
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

This mechanism has no published performance targets or indicators.